Cancer: Immunotherapy
DISEASE INTERVENTION COMPARISON RESULTS
Lancet. 1999 Jan 30;353(9150):345-50 Randomized Controlled Trial
IN cancer, colorectal The Use of
Immunotherapy, individualized tumor vaccine, after resection
As Treatment, Acute
Is better Than
no treatment
To reduce any cancer recurrence at 5 years: 19.5% vaccine VS 31.7% no-vaccine
N Engl J Med. 2008 Jun 19;358(25):2698-703 Descriptive
IN cancer, melanome, metastatic The Use of
autologous T-cell therapy, autologous CD4+ T cells against NY-ESO-1
As Treatment, Acute
Is better Than
no treatment
To Results to be defined